Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)

53.87
Delayed Data
As of 4:00pm ET
 -1.04 / -1.89%
Today’s Change
41.67
Today|||52-Week Range
71.99
+16.15%
Year-to-Date
No recent news for Ultragenyx Pharmaceutical Inc.

Today’s Trading

Previous close54.91
Today’s open54.89
Day’s range53.67 - 55.36
Volume464,588
Average volume (3 months)534,968
Market cap$2.7B
Data as of 4:00pm ET, 04/19/2018

Growth & Valuation

Earnings growth (last year)-14.65%
Earnings growth (this year)+17.84%
Earnings growth (next 5 years)-41.24%
Revenue growth (last year)+1,863.91%
P/E ratioNM
Price/Sales753.82
Price/Book6.20

Competitors

 Today’s
change
Today’s
% change
IRWDIronwood Pharmaceuti...-0.03-0.17%
LOXOLoxo Oncology Inc-0.62-0.46%
PRTAProthena Corporation...-1.04-2.89%
SUPNSupernus Pharmaceuti...+0.80+1.66%
Data as of 4:00pm ET, 04/19/2018

Financials

Next reporting dateMay 14, 2018
EPS forecast (this quarter)-$1.94
Annual revenue (last year)$2.6M
Annual profit (last year)-$302.1M
Net profit margin-11,567.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Emil D. Kakkis
Chief Financial Officer &
Executive Vice President
Shalini Sharp
Corporate headquarters
Novato, California

Forecasts